Insider · CIK 0001319872

Cogan John Francis

Reports to the SEC for 4 companies · STANFORD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001319872

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-05-04	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,416 sh	—	—	0
2020-05-04	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−2,416 sh	$81.75	−$198K	54,860
2020-05-04	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,416 sh	$19.63	+$47.4K	57,276
2020-04-27	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,413 sh	$19.63	+$47.4K	57,273
2020-04-27	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,413 sh	—	—	2,416
2020-04-27	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−2,413 sh	$79.90	−$193K	54,860
2020-04-20	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,413 sh	$19.63	+$47.4K	57,273
2020-04-20	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,413 sh	—	—	4,829
2020-04-20	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−2,413 sh	$83.00	−$200K	54,860
2020-04-13	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,413 sh	$19.63	+$47.4K	57,273
2020-04-13	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,413 sh	—	—	7,242
2020-04-13	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−2,413 sh	$75.90	−$183K	54,860
2020-04-06	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−2,413 sh	$79.52	−$192K	54,860
2020-04-06	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,413 sh	$19.63	+$47.4K	57,273
2020-04-06	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,413 sh	—	—	9,655
2020-03-30	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,413 sh	—	—	12,068
2020-03-30	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−2,413 sh	$75.35	−$182K	54,860
2020-03-30	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,413 sh	$19.63	+$47.4K	57,273
2020-03-23	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−2,413 sh	$75.27	−$182K	54,860
2020-03-23	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,413 sh	$19.63	+$47.4K	57,273
2020-03-23	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,413 sh	—	—	14,481
2020-03-16	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,413 sh	$19.63	+$47.4K	57,273
2020-03-16	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,413 sh	—	—	16,894
2020-03-16	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−2,413 sh	$67.26	−$162K	54,860
2020-03-09	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,413 sh	—	—	19,307
2020-03-09	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−2,413 sh	$77.97	−$188K	54,860
2020-03-09	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,413 sh	$19.63	+$47.4K	57,273
2019-05-08	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitA Award	Director	AAward	+2,270 sh	—	—	4,553
2019-05-08	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)A Award	Director	AAward	+11.8K sh	—	—	11,848
2019-05-01	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,868 sh	$22.02	+$63.1K	57,728
2019-05-01	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−2,868 sh	$64.89	−$186K	54,860
2019-05-01	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,868 sh	—	—	0
2019-04-24	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−2,700 sh	$62.61	−$169K	54,860
2019-04-24	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,700 sh	—	—	2,868
2019-04-24	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,700 sh	$22.02	+$59.4K	57,560
2019-04-17	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−100 sh	$64.66	−$6,466	54,860
2019-04-17	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,700 sh	—	—	5,568
2019-04-17	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,700 sh	$22.02	+$59.4K	57,560
2019-04-17	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−2,600 sh	$64.21	−$167K	54,960
2019-04-10	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,700 sh	$22.02	+$59.4K	57,560
2019-04-10	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,700 sh	—	—	8,268
2019-04-10	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−2,700 sh	$67.23	−$182K	54,860
2019-04-03	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,700 sh	—	—	10,968
2019-04-03	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−2,700 sh	$66.74	−$180K	54,860
2019-04-03	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,700 sh	$22.02	+$59.4K	57,560
2019-03-27	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,700 sh	—	—	13,668
2019-03-27	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−2,700 sh	$64.14	−$173K	54,860
2019-03-27	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,700 sh	$22.02	+$59.4K	57,560
2019-03-20	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,700 sh	—	—	16,368
2019-03-20	GILDGILEAD SCIENCES, INC.S Sale	Director	SSale	−2,700 sh	$65.07	−$176K	54,860

Recent filings

Accepted (ET)
May 54
Cogan John Francis0001127602-20-015427
SEC(opens sec.gov)
Apr 294
Cogan John Francis0001127602-20-014714
SEC(opens sec.gov)
Apr 214
Cogan John Francis0001127602-20-014247
SEC(opens sec.gov)
Apr 144
Cogan John Francis0001127602-20-013679
SEC(opens sec.gov)
Apr 74
Cogan John Francis0001127602-20-013405
SEC(opens sec.gov)
Mar 314
Cogan John Francis0001127602-20-012212
SEC(opens sec.gov)
Mar 244
Cogan John Francis0001127602-20-011900
SEC(opens sec.gov)

Companies

Address

HOOVER INSTITUTION 434 GALVEZ MALL

STANFORD, CA, 94305-6010